A prospective comparison of fungal load in paired sputum and bronchoalveolar lavage fluid for Pneumocystis pneumonia diagnosis: Clinical thresholds and diagnostic accuracy.
{"title":"A prospective comparison of fungal load in paired sputum and bronchoalveolar lavage fluid for Pneumocystis pneumonia diagnosis: Clinical thresholds and diagnostic accuracy.","authors":"Pakpoom Phoompoung, Peewara Thampanyawat, Anupop Jitmuang, Kamontip Kunwipakorn, Thipsuda Phornkhakhanumphorn, Nattapon Thanintorn, Patsharaporn Techasintana Sarasombath","doi":"10.1016/j.jmii.2025.08.026","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To compare diagnostic performances and accuracy of non-invasive specimens and bronchoalveolar lavage fluid (BALF) for diagnosing Pneumocystis pneumonia (PCP) in immunocompromised pneumonia patients.</p><p><strong>Methods: </strong>A prospective study of 112 immunocompromised patients to evaluate P. jirovecii fungal loads in paired sputum and BALF from the same patients. Patients were classified as definite PCP, probable PCP, and non-PCP based on criteria blinded to qPCR results. Optimal diagnostic cut-offs were derived, and agreement between specimen types was analyzed.</p><p><strong>Results: </strong>A BALF fungal load threshold of 2,613 DNA copies/μL demonstrated high sensitivity (82.6 %, 95 % CI: 62.9-93.0) and specificity (96.7 %, 95 % CI: 90.8-99.1) for PCP diagnosis. In sputum, a cut-off of 474 DNA copies/μL offered moderate sensitivity (65.2 %, 95 % CI: 44.9-81.2) and high specificity (89.0 %, 95 % CI: 80.9-93.9), enabling the exclusion of PCP in patients with low clinical suspicion. Fungal loads in sputum correlated well with BALF but showed greater variability in confirmed PCP cases, highlighting limitations for non-invasive diagnosis in high-risk patients.</p><p><strong>Conclusion: </strong>Non-invasive fungal load in sputum provides a valuable tool for excluding PCP in immunocompromised pneumonia patients, potentially reducing the need for bronchoscopy.</p>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Microbiology Immunology and Infection","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jmii.2025.08.026","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: To compare diagnostic performances and accuracy of non-invasive specimens and bronchoalveolar lavage fluid (BALF) for diagnosing Pneumocystis pneumonia (PCP) in immunocompromised pneumonia patients.
Methods: A prospective study of 112 immunocompromised patients to evaluate P. jirovecii fungal loads in paired sputum and BALF from the same patients. Patients were classified as definite PCP, probable PCP, and non-PCP based on criteria blinded to qPCR results. Optimal diagnostic cut-offs were derived, and agreement between specimen types was analyzed.
Results: A BALF fungal load threshold of 2,613 DNA copies/μL demonstrated high sensitivity (82.6 %, 95 % CI: 62.9-93.0) and specificity (96.7 %, 95 % CI: 90.8-99.1) for PCP diagnosis. In sputum, a cut-off of 474 DNA copies/μL offered moderate sensitivity (65.2 %, 95 % CI: 44.9-81.2) and high specificity (89.0 %, 95 % CI: 80.9-93.9), enabling the exclusion of PCP in patients with low clinical suspicion. Fungal loads in sputum correlated well with BALF but showed greater variability in confirmed PCP cases, highlighting limitations for non-invasive diagnosis in high-risk patients.
Conclusion: Non-invasive fungal load in sputum provides a valuable tool for excluding PCP in immunocompromised pneumonia patients, potentially reducing the need for bronchoscopy.
期刊介绍:
Journal of Microbiology Immunology and Infection is an open access journal, committed to disseminating information on the latest trends and advances in microbiology, immunology, infectious diseases and parasitology. Article types considered include perspectives, review articles, original articles, brief reports and correspondence.
With the aim of promoting effective and accurate scientific information, an expert panel of referees constitutes the backbone of the peer-review process in evaluating the quality and content of manuscripts submitted for publication.